CREB1 and Alzheimer disease: Further investigation revealed 25 increased CREB phosphorylation levels, plus in Tg2576 neurons, reduced levels of the AD-related markers hAPP (human amyloid precursor protein) and pTau (phosphorylated tau protein) by 55% and 30%, respectively, following 100 nM treatment for two days [131].